230 related articles for article (PubMed ID: 25651976)
1. Where does allogeneic stem cell transplantation fit in the treatment of chronic lymphocytic leukemia?
Dreger P; Montserrat E; ;
Curr Hematol Malig Rep; 2015 Mar; 10(1):59-64. PubMed ID: 25651976
[TBL] [Abstract][Full Text] [Related]
2. Treatment of Chronic Lymphocytic Leukemia With del(17p)/TP53 Mutation: Allogeneic Hematopoietic Stem Cell Transplantation or BCR-Signaling Inhibitors?
Montserrat E; Dreger P
Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S74-81. PubMed ID: 27521330
[TBL] [Abstract][Full Text] [Related]
3. Prognostic markers and standard management of chronic lymphocytic leukemia.
Stilgenbauer S
Hematology Am Soc Hematol Educ Program; 2015; 2015():368-77. PubMed ID: 26637745
[TBL] [Abstract][Full Text] [Related]
4. [Chronic lymphocytic leukemia : treatment concepts in transition].
Eichhorst B; Hallek M
Internist (Berl); 2015 Apr; 56(4):374-80. PubMed ID: 25776793
[TBL] [Abstract][Full Text] [Related]
5. Spotlight on chronic lymphocytic leukemia: a Pharma Matters report.
D'Souza P; Walker G
Drugs Today (Barc); 2014 Jul; 50(7):485-501. PubMed ID: 25101331
[TBL] [Abstract][Full Text] [Related]
6. Clinical Practice Recommendations for Use of Allogeneic Hematopoietic Cell Transplantation in Chronic Lymphocytic Leukemia on Behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation.
Kharfan-Dabaja MA; Kumar A; Hamadani M; Stilgenbauer S; Ghia P; Anasetti C; Dreger P; Montserrat E; Perales MA; Alyea EP; Awan FT; Ayala E; Barrientos JC; Brown JR; Castro JE; Furman RR; Gribben J; Hill BT; Mohty M; Moreno C; O'Brien S; Pavletic SZ; Pinilla-Ibarz J; Reddy NM; Sorror M; Bredeson C; Carpenter P; Savani BN
Biol Blood Marrow Transplant; 2016 Dec; 22(12):2117-2125. PubMed ID: 27660167
[TBL] [Abstract][Full Text] [Related]
7. Managing high-risk CLL during transition to a new treatment era: stem cell transplantation or novel agents?
Dreger P; Schetelig J; Andersen N; Corradini P; van Gelder M; Gribben J; Kimby E; Michallet M; Moreno C; Stilgenbauer S; Montserrat E;
Blood; 2014 Dec; 124(26):3841-9. PubMed ID: 25301705
[TBL] [Abstract][Full Text] [Related]
8. Allogeneic hematopoietic stem-cell transplantation for chronic lymphocytic leukemia with 17p deletion: a retrospective European Group for Blood and Marrow Transplantation analysis.
Schetelig J; van Biezen A; Brand R; Caballero D; Martino R; Itala M; García-Marco JA; Volin L; Schmitz N; Schwerdtfeger R; Ganser A; Onida F; Mohr B; Stilgenbauer S; Bornhäuser M; de Witte T; Dreger P
J Clin Oncol; 2008 Nov; 26(31):5094-100. PubMed ID: 18711173
[TBL] [Abstract][Full Text] [Related]
9. Bruton tyrosine kinase inhibition in chronic lymphocytic leukemia.
Maddocks K; Jones JA
Semin Oncol; 2016 Apr; 43(2):251-9. PubMed ID: 27040703
[TBL] [Abstract][Full Text] [Related]
10. The evolving role of hematopoietic cell transplantation in chronic lymphocytic leukemia.
Davids MS; Alyea EP
Curr Hematol Malig Rep; 2015 Mar; 10(1):18-27. PubMed ID: 25682168
[TBL] [Abstract][Full Text] [Related]
11. [Ultra high risk chronic lymphocytic leukemia - characteristics and treatment options].
Lysák D; Jindra P
Vnitr Lek; 2013 Oct; 59(10):887-94. PubMed ID: 24164366
[TBL] [Abstract][Full Text] [Related]
12. Refractory and 17p-deleted chronic lymphocytic leukemia: improving survival with pathway inhibitors and allogeneic stem cell transplantation.
Farina L; Barretta F; Scarfò L; Bruno B; Patriarca F; Frustaci AM; Coscia M; Salvetti C; Quaresmini G; Fanin R; Onida F; Magagnoli M; Zallio F; Vallisa D; Reda G; Ferrario A; Corradini P; Montillo M
Biol Blood Marrow Transplant; 2020 Oct; 26(10):e256-e262. PubMed ID: 32653626
[TBL] [Abstract][Full Text] [Related]
13. Advances in the diagnosis and treatment of chronic lymphocytic leukemia.
Abbott BL
Hematol Oncol; 2005 Mar; 23(1):34-40. PubMed ID: 16149106
[TBL] [Abstract][Full Text] [Related]
14. BCR signaling in chronic lymphocytic leukemia and related inhibitors currently in clinical studies.
Robak T; Robak P
Int Rev Immunol; 2013 Aug; 32(4):358-76. PubMed ID: 23617253
[TBL] [Abstract][Full Text] [Related]
15. Management of chronic lymphocytic leukemia (CLL) in the era of B-cell receptor signal transduction inhibitors.
Mato A; Jauhari S; Schuster SJ
Am J Hematol; 2015 Jul; 90(7):657-64. PubMed ID: 25808792
[TBL] [Abstract][Full Text] [Related]
16. [Chronic lymphocytic leukemia: biology, disease progression, and current treatment strategies].
Yano T
Rinsho Ketsueki; 2017; 58(10):1960-1972. PubMed ID: 28978838
[TBL] [Abstract][Full Text] [Related]
17. What do we do with chronic lymphocytic leukemia with 17p deletion?
Sellner L; Denzinger S; Dietrich S; Glimm H; Merkel O; Dreger P; Zenz T
Curr Hematol Malig Rep; 2013 Mar; 8(1):81-90. PubMed ID: 23188619
[TBL] [Abstract][Full Text] [Related]
18. [Evidence-based therapy for chronic leukemia].
Okamoto S
Nihon Naika Gakkai Zasshi; 2003 Jun; 92(6):979-85. PubMed ID: 12866442
[No Abstract] [Full Text] [Related]
19. Treatment-related mortality and graft-versus-leukemia activity after allogeneic stem cell transplantation for chronic lymphocytic leukemia using intensity-reduced conditioning.
Dreger P; Brand R; Hansz J; Milligan D; Corradini P; Finke J; Deliliers GL; Martino R; Russell N; Van Biezen A; Michallet M; Niederwieser D;
Leukemia; 2003 May; 17(5):841-8. PubMed ID: 12750695
[TBL] [Abstract][Full Text] [Related]
20. An unusual presentation of a chronic lymphocytic leukemia patient with 17p deletion after reduced-intensity transplantation: Richter syndrome and concomitant graft-versus-host disease--case report.
Salihoglu A; Ozbalak M; Keskin D; Tecimer T; Soysal T; Ferhanoglu B
Transplant Proc; 2013 Sep; 45(7):2845-8. PubMed ID: 23747187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
